352 related articles for article (PubMed ID: 27521836)
1. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
[TBL] [Abstract][Full Text] [Related]
2. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
Bencsik P; Pálóczi J; Kocsis GF; Pipis J; Belecz I; Varga ZV; Csonka C; Görbe A; Csont T; Ferdinandy P
Pharmacol Res; 2014 Feb; 80():36-42. PubMed ID: 24380772
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
[TBL] [Abstract][Full Text] [Related]
5. Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT
Mendoza-Torres E; Riquelme JA; Vielma A; Sagredo AR; Gabrielli L; Bravo-Sagua R; Jalil JE; Rothermel BA; Sanchez G; Ocaranza MP; Lavandero S
Pharmacol Res; 2018 Sep; 135():112-121. PubMed ID: 30048754
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
7. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage.
Ahmet I; Tae HJ; Juhaszova M; Riordon DR; Boheler KR; Sollott SJ; Brines M; Cerami A; Lakatta EG; Talan MI
Mol Med; 2011; 17(3-4):194-200. PubMed ID: 21170473
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
9. Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia.
Torregroza C; Yueksel B; Ruske R; Stroethoff M; Raupach A; Heinen A; Hollmann MW; Huhn R; Feige K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926009
[TBL] [Abstract][Full Text] [Related]
10. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury.
Fiordaliso F; Chimenti S; Staszewsky L; Bai A; Carlo E; Cuccovillo I; Doni M; Mengozzi M; Tonelli R; Ghezzi P; Coleman T; Brines M; Cerami A; Latini R
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2046-51. PubMed ID: 15671158
[TBL] [Abstract][Full Text] [Related]
11. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
12. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors.
Gömöri K; Szabados T; Kenyeres É; Pipis J; Földesi I; Siska A; Dormán G; Ferdinandy P; Görbe A; Bencsik P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977437
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
Jun JH; Jun NH; Shim JK; Shin EJ; Kwak YL
Eur J Pharmacol; 2014 Dec; 745():1-9. PubMed ID: 25446919
[TBL] [Abstract][Full Text] [Related]
15. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.
Wright GL; Hanlon P; Amin K; Steenbergen C; Murphy E; Arcasoy MO
FASEB J; 2004 Jun; 18(9):1031-3. PubMed ID: 15059965
[TBL] [Abstract][Full Text] [Related]
17. Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro.
Bullard AJ; Yellon DM
Cardiovasc Drugs Ther; 2005 Oct; 19(5):333-6. PubMed ID: 16382295
[TBL] [Abstract][Full Text] [Related]
18. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
[TBL] [Abstract][Full Text] [Related]
19. Experimental acute myocardial infarction in rats: HIF-1α, caspase-3, erythropoietin and erythropoietin receptor expression and the cardioprotective effects of two different erythropoietin doses.
Guven Bagla A; Ercan E; Asgun HF; Ickin M; Ercan F; Yavuz O; Bagla S; Kaplan A
Acta Histochem; 2013 Sep; 115(7):658-68. PubMed ID: 23453036
[TBL] [Abstract][Full Text] [Related]
20. The potential of erythropoietin for conferring cardioprotection complementing reperfusion.
Binbrek AS; Mittal B; Rao KN; Sobel BE
Coron Artery Dis; 2007 Nov; 18(7):583-5. PubMed ID: 17925614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
